Search Knowledge Base

1 result for "myeloproliferative-disorders"

A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms pubmed_article
Evidence Source 2021 PMID: 33570633

Evidence Search Results semantic · quality-ranked

A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms meta_analysis pubmed_article
Quality: 66 2021 PMID: 33570633 DOI: 10.1182/bloodadvances.2020003628
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents systematic_review pubmed_article
Quality: 72 2021 PMID: 34582035 DOI: 10.1002/14651858.CD014739
Iron chelation therapy for myelodysplastic syndrome: a systematic review and meta-analysis meta_analysis pubmed_article
Quality: 64 2020 PMID: 31712933 DOI: 10.1007/s10238-019-00592-5
Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis meta_analysis pubmed_article
Quality: 65 2022 PMID: 35764087 DOI: 10.1016/j.xcrm.2022.100670
Copper deficiency myelopathy mimicking cervical spondylitic myelopathy: a systematic review of the literature with case report systematic_review pubmed_article
Quality: 56 2024 PMID: 38909910 DOI: 10.1016/j.spinee.2024.06.018
Pharmacological treatment for Buerger's disease meta_analysis pubmed_article
Quality: 72 2016 PMID: 26828199 DOI: 10.1002/14651858.CD011033.pub2
Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review systematic_review pubmed_article
Quality: 59 2024 PMID: 38245797 DOI: 10.1186/s13023-024-03021-3
Pharmacological treatment for Buerger's disease meta_analysis pubmed_article
Quality: 71 2016 PMID: 26967103 DOI: 10.1002/14651858.CD011033.pub3
Treatment for mitochondrial disorders meta_analysis pubmed_article
Quality: 67 2012 PMID: 22513923 DOI: 10.1002/14651858.CD004426.pub3
Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib systematic_review pubmed_article
Quality: 53 2022 PMID: 36358997 DOI: 10.3390/biom12111647

View full evidence search →